HYLN Hyliion Holdings Corp. Insider Trading

Director Freeland buys 65,000 HYLN shares at $1.57; holdings up 41.2% to 222.8K shares post-acquisition

Director Richard Joseph Freeland purchased 65,000 shares at $1.57 for $102,050.00, increasing his holdings by 41.2% to 222,798 shares. The acquisition occurs at a price -58.8% below the 52-week high of $3.84, and the stock is down -4.8% over the last 30 days despite a +31.7% 90-day gain. Hyliion remains unprofitable with net income of $-13,414,000.00 in the latest quarter and recorded negative full-year earnings; however, annual revenue growth reached +124.6%. Freeland's cross-ticker track record shows a 100% win rate on 90-day holds (1 prior buy with avg 90d return of +1.3%), though the sample size is minimal and same-ticker measurable history is absent.

CFO Panzer Jon bought 40,000 shares of HYLN at $1.14; cluster buy pattern with 2 other insiders in 14 days

Jon Panzer, CFO, purchased 40,000 shares at $1.14 on 2025-05-23, increasing his holdings from 885,669 shares to 925,669 shares (+4.5%). This purchase occurs within a broader cluster: 2 other insiders bought HYLN within the past 14 days, suggesting coordinated or synchronized conviction at the current depressed valuation. Panzer's cross-ticker track record shows 1 prior buy with a 90-day return of +90.5%, and his same-ticker history (1 prior buy at HYLN on 2023-11-14) delivered +90.5% over 90 days and was well-timed. However, the stock is currently trading at $1.14, -70.3% from its 52-week high of $3.84 and down 29.2% over 30 days and 38.7% over 90 days. The company generated $489.0K in latest-quarter revenue but posted a $-17.3M net loss, with full-year net income negative. The buy timing relative to historical precedent is favorable, but the deteriorating price action and unprofitable fundamentals create material tension in the investment signal.

CCO Ramasamy Govindaraj buys 20,000 HYLN shares at $1.13; prior HYLN buys at 26.6% (30d) and 68.8% (90d) returns; cluster pattern with 2 other insiders in 14 days

Ramasamy Govindaraj, Chief Commercial Officer, purchased 20,000 shares at $1.13 on 2025-05-23, expanding his holdings by 3.6% to 573,002 shares. His two prior open-market purchases at Hyliion achieved 30-day returns of 26.6% and 34.7%, and 90-day returns of 68.8% and 18.0%, demonstrating a pattern of well-timed entries at this ticker. This transaction occurs as part of a cluster, with 2 other insiders also buying within the past 14 days. The stock is trading 70.3% below its 52-week high and has declined 38.7% over 90 days, occurring against a backdrop where the company generated $489.0K in latest-quarter revenue but reported $-17.3M in net income. The convergence of recurring insider buying activity at a depressed valuation point, combined with coordinated cluster activity, represents a material signal to monitor against upcoming business developments.

CFO Greg Standley buys 5,000 shares at $1.13 as HYLN falls -70.3% from 52-week high; cluster pattern with 2 other insiders buying within 14 days

Standley, serving as Chief Accounting Officer, purchased 5,000 shares at $1.13 on 2025-05-23, increasing his holdings from 236,659 to 241,659 shares. The transaction occurred against a backdrop of severe price deterioration: the stock trades at $1.14 (current price), down 70.3% from its 52-week high of $3.84 and down 29.2% over the prior 30 days. The company is unprofitable with a net loss of $17,254,000.00 on quarterly revenue of $489,000.00, though annual revenue growth was +124.6%. A cluster pattern exists—2 other insiders also bought within the past 14 days—suggesting coordinated response to valuation levels rather than isolated opportunism. For investors, this filing requires scrutiny of whether multi-insider purchases at depressed valuations reflect genuine conviction in recovery prospects or represent routine maintenance of equity stakes amid operational challenges.

Director Craig Jeffrey A purchased 50,000 shares of HYLN at $2.95 on 2024-11-20, bringing holdings to 282,060 shares (+21.5%).

Craig Jeffrey A, a director at Hyliion Holdings, purchased 50,000 shares for $147,500.00, representing a substantial 21.5% increase to his post-transaction holdings of 282,060 shares. The purchase occurred near the upper end of the 52-week range ($0.55–$3.11), with the stock trading at $2.95, just 6.4% below its 52-week high. Prior to this purchase, Jeffrey completed a similar buy at the same ticker on 2023-11-15, which captured a 76.2% gain over 90 days—a well-timed entry. However, the company's fundamentals present material constraints: the firm generated $0.00 revenue in the latest quarter, posted a net loss of $-11,200,000.00, and experienced -68.1% annual revenue decline, while remaining unprofitable on a full-year basis. The timing of this open-market buy follows positive price momentum (stock up +15.9% over 30 days and +49.2% over 90 days), creating a tension between the director's demonstrated skill in prior entry timing at this ticker and the company's deteriorating operational trajectory.

Hyliion CCO Ramasamy Govindaraj buys 30,000 shares at $1.92; prior trade at this ticker returned 18.0% over 90 days

Ramasamy Govindaraj, Chief Commercial Officer, purchased 30,000 shares at $1.92 on 2024-09-11, growing his holdings to 298,000 shares. The current price of $1.87 sits -24.9% from the 52-week high, while the stock has gained 26.4% over the past 90 days. His prior transaction at Hyliion on 2024-06-12 delivered a 90-day return of 18.0%, indicating his previous timing at this ticker was well-timed; he also maintains a 100.00% win rate across his cross-ticker open-market buy history. However, context matters: the company is unprofitable with a net loss of $10,856,000.00 in the latest quarter, annual revenue declined 68.1% year-over-year, and current quarterly revenue stands at $0.00. This purchase occurs against deteriorating fundamentals, and the stock's recent 6.0% decline over 30 days warrants scrutiny of execution environment and strategic positioning.

CCO Ramasamy Govindaraj purchases 10,000 shares of HYLN at $1.50 amid -68.1% revenue decline and $-15.6M net loss.

Ramasamy Govindaraj, Chief Commercial Officer, purchased 10,000 shares at $1.50 on 2024-06-12, increasing his holdings from 217,500 to 227,500 shares. The transaction occurs in a severely distressed fundamental context: the company generated $0.00 in latest-quarter revenue and reported a full-year net income of $-15,600,000.00, while annual revenue growth contracted by -68.1%. The current price of $1.49 is -31.0% below the 52-week high and the stock has declined -6.3% over the past 30 days, though it has recovered +2.8% over 90 days. As the executive responsible for commercial operations, the CCO's purchase may warrant scrutiny given the company's severe revenue collapse and ongoing unprofitability, but the modest position increase of 4.6% relative to prior holdings and the low nominal dollar amount ($15,000.00) provide limited visibility into management's conviction or strategic intentions.